drugset / Trial / NCT02984722

Extended-release vs Immediate-release Metformin in PCOS Women

NCT02984722 ↗

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The aim of our study is to compare the different effects of 6 months treatment with extended-release metformin and immediate-release metformin on clinical, endocrine and metabolic parameters in women affected by polycystic ovary syndrome. We also evaluate gastrointestinal disorders associated with the two different compouds.

Timeline

Start
2016-12
Primary completion
2017-12
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 1500 mg —